Literature DB >> 6685823

Long-term sensitization to the excitatory effects of morphine. A motility study in post-dependent rats.

M Bartoletti, M Gaiardi, G Gubellini, A Bacchi, M Babbini.   

Abstract

Motility effects of excitatory and depressant doses of morphine were studied in naïve, dependent (20 mg/kg daily) and post-dependent (about 40 days after withdrawal) rats. Doses of 0.6 and 1.25 mg/kg of morphine produced a greater increase in activity in post-dependent than in naïve rats. A 20-mg/kg dose exerted an excitatory effect in dependent rats instead of the depressant one induced in naïve animals. This excitatory effect was still evident but less pronounced in post-dependent rats. The dose of 1.25 mg/kg was repeatedly challenged in post-dependent (80 mg/kg daily) rats. It was found that the increased excitatory effect of this dose persisted unchanged 160 days after ceasing treatment. The present results demonstrate that several months after the withdrawal of morphine, sensitization still exists to the excitatory effect of the drug while tolerance to the depressant action is slight or no longer present shortly after ceasing treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685823     DOI: 10.1016/0028-3908(83)90080-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  22 in total

1.  Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections.

Authors:  D C Hoffman; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum.

Authors:  John McDaid; Jeanine E Dallimore; Alexander R Mackie; T Celeste Napier
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

Review 3.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

Review 4.  Estradiol: a key biological substrate mediating the response to cocaine in female rats.

Authors:  Annabell C Segarra; José L Agosto-Rivera; Marcelo Febo; Natasha Lugo-Escobar; Raissa Menéndez-Delmestre; Anabel Puig-Ramos; Yvonne M Torres-Diaz
Journal:  Horm Behav       Date:  2009-12-21       Impact factor: 3.587

5.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

6.  Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Authors:  Katharine M Seip-Cammack; Brian Reed; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

7.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

8.  Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats: role of mu-opioid receptors.

Authors:  Lucía Hipólito; María-José Sánchez-Catalán; Teodoro Zornoza; Ana Polache; Luis Granero
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

9.  Biotelemetric investigation of morphine's thermic and kinetic effects in rats.

Authors:  R Dafters; P Taggart
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization.

Authors:  Mikhail Kalinichev; David A White; Stephen G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  2004-08-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.